CRISPR THERAPEUTIC financial statements, including revenue, expenses, profit, and loss

The total revenue of 1CG for the last quarter is 454.67 k CHF, and it's 99.73% lower compared to the previous quarter. The net income of Q1 24 is -105.18 M CHF.